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Sllrnmary 
The genesis of human follicular lymphoma (FL) is a multistep process. The initial event is thought 
to be the chromosomal translocation t(14;18)(q32;q21)juxtaposing the be/-2 proto-oncogene with 
the immunoglobulin (Ig) H chain locus joining segment 0.) as an error of D-J or V-D joining 
in the pre-B cell. However, FL is recognized clinically as a tumor of surface Ig (slg)-positive 
B cells with morphologic and phenotypic similarities to the centrocyte  of the secondary immune 
response. Thus, additional steps must be involved in the clonal expansion of the FL tumor cell 
beyond the activation of bc/-2 as a consequence of the t(14;18) translocation.  Like the normal 
centrocyte, somatic mutations accumulate  in the variable (V) genes of FL tumor B cells. To determine 
if clonal expansion of FL occurs before or after the development of the malignant follicle, we 
sought to examine the evolution of the FL V gene from its unmutated germline (GL) counterpart. 
To obtain  the GL gene we first cloned the productively rearranged V gene of patient MT FL 
and obtained the clone rMTF. A hybridization  probe derived from the 2.1-kb region upstream 
of the V gene in clone rMTF identified a single band in Southern blot hybridization  of GL 
DNA. This probe was used to screen a size-selected library, and candidate GL V genes were 
isolated. Two identical clones, MTGL1 and 2,  proved to have upstream regions (USRs)  that 
were colinear with the USR of the rMTF.  Thus, the MTGL clones represent the unmutated 
GL V genes, which were productively rearranged in the MT FL. Comparison of the GL V gene 
sequence to a consensus of MT FL V gene sequences revealed 42 mutations, demonstrating that 
malignant clonal expansion occurred subsequent to the activation of somatic mutation, presumably 
in the malignant follicle. Furthermore, the individual FL V gene sequences segregated into two 
distinct  patterns of mutation. The major population represented 71%  of the clones, and the 
minor population 29%. To investigate possible mechanisms for the parallel selection of distinct 
tumor cell populations,  we analyzed the pattern of silent and replacement mutations within 
the V gene sequences. We found that in the framework regions (FRs) of both populations there 
were significantly fewer replacement changes than expected, suggesting  that negative selective 
pressure was maintaining the structural integrity of the slg.  In contrast,  the complementarity 
determining regions (CDRs), which make up the antigen binding domain of Ig, had an excess 
of replacement changes, suggesting positive selection for altered ligand binding.  The findings 
of positive selection of CDRs and of negative selection of FRs support the hypothesis that the 
slg was under selective pressure, presumably by antigen in both subpopulations  of this tumor. 
Thus, we propose a model of stepwise development of  FL beginning with the t(14;18) translocation 
followed by antigen-driven  clonal expansion. 
H 
uman follicular lymphoma (FL)  1 is a low-grade indo- 
lent B cell lymphoma (1) with a propensity to progress 
to diffuse large cell lymphoma in up to 65% of  patients within 
10 yr of diagnosis (2-5). Cytogenetic and molecular studies 
1  Abbreviations used in this paper: FL, follicular lymphoma; GC, germinal 
center; GL, germline; mbr, major breakpoint region; R/S,  replacement 
to silent mutations; slg, surface immunoglobulin. 
have demonstrated that 90% of these tumors possess a specific 
chromosomal translocation,  t(14;18)(q32;q21), which  juxta- 
poses the joining segment 0.) of the Ig H  chain locus on 
chromosome 14 and the be/-2 proto-oncogene on chromo- 
some 18 (6-12). Data suggest that FL originates in the bone 
marrow (13) where the chromosomal translocation  occurs 
in a pre-B cell as an error in D-J or V-D joining (14-18). 
The frequency of the t(14;18) in FL suggests that activation 
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phomagenesis.  However, several lines of evidence suggest the 
t(14;18) translocation alone is not su~cient to produce the 
malignant phenotype. Transgeneic mice expressing a dysregn- 
lated be/-2 demonstrate polyclonal follicular hyperplasia and 
extended B cell survival (19). A donal, malignant phenotype 
requires either a stochastic second event (20) or coexpression 
of a second proto-oncogene (21, 22). Furthermore, FL is in- 
variably a tumor of mature B cells with clonal H and L chain 
rearrangements. Provocatively, a recent report suggested that 
the t(14;18) translocation can be detected in some normal tonsil 
tissue by sensitive PCR assays (23),  suggesting its presence 
does not inevitably lead to lymphomagenesis. 
The malignant cell in FL has a number of parallels to the 
centrocyte of the secondary immune response. Morphologi- 
cally and phenotypically the two cell populations are very 
similar.  The architecture of the malignant follicle is strik- 
ingly similar to the germinal center (GC) of the secondary 
immune response; both are characterized by the presence of 
follicular dendritic cells (FDC) and CD4 + T cells (24). Like 
the centrocyte, the FL cell expresses  the integrin very late 
antigen 4 (VLA-4), which mediates binding to follicular den- 
tritic cells via interaction with vascular cell adhesion mole- 
cule 1 (VCAM-1)  (25).  They share the expression of CD10 
and LFA-1 as well as surface immunoglobulin (slg) (26-29). 
In both the normal and malignant cells, the Ig V genes are 
altered by somatic hypermutation (30, 31). Given the striking 
similarity of the FL cell and the normal centrocyte, we wanted 
to determine if expansion of the FL tumor done occurred 
in the malignant follicle. Though B cells have the capacity 
to undergo donal expansion at several stages of development, 
our focus was the expansion of the FL tumor clone, which 
results in clinically detectable disease (malignant donal ex- 
pansion).  To examine the stage  of B cell ontogeny during 
which malignant clonal expansion occurs, we sought to ex- 
ploit the observation that as a result of ongoing somatic mu- 
tation of Ig genes, each FL cell in the tumor population has 
a slightly different Ig V,  and VL sequence.  Thus,  the se- 
quences of these V genes from individual cells within a tumor 
can provide data regarding donal relatedness. Previously, we 
used this tool to demonstrate that transformed diffuse lym- 
phoma arose from a single FL cell (5). In the current study, 
we compared the pattern of mutation in the FL V gene to 
the germline (GL) V gene. A probe, upstream region sequence 
2 (USR2),  isolated from a region between 1.2 and 2.1 kb 
upstream of the productively rearranged H  chain Ig allele 
from the FL, identified a unique GL V gene. Using this USR 
probe the GL V  gene was cloned. The comparison of se- 
quences obtained from the GL with those isolated from the 
FL demonstrates that malignant clonal expansion of FL oc- 
curred when somatic mutation was ongoing; thus, it was 
presumably in the GC. This finding supports the conclusion 
that events secondary to the t(14;18) contribute to the devel- 
opment of FL occurring in the B cell,  not the pre-B  cell. 
Strikingly, the case of FL analyzed in this paper is composed 
of two populations with distinct patterns of nonrandom mu- 
tation relative to the GL. Application of the mutational analysis 
proposed by Shlomchik et al.  (32,  33)  to the current data 
supports the conclusions that the evolution of the GL to FL 
involved  antigenic selection. 
Materials and Methods 
Tumor Material.  Patient  MT underwent biopsy at various  points 
in time and the tumor material was stored as a single cell suspen- 
sion as previously described (34). The initial FL was biopsied in 
May 1987. 
Cellular DNA  and RNA  Isolation.  Total  cellular RNA and 
genomic DNA was prepared by the guanidinium isothiocyanate/ 
CsC1 method (35) as previously described (5). GL DNA was ob- 
tained from semen as previously described (36). 
Southern Hybridization Analyses.  DNA transfer to a positively 
charged nylon membrane (ZetaBind; CUNO, Meriden, CT) was 
performed by vacuum blotting as recommended by the manufac- 
turer (LKB,  Bromma, Sweden),  with the exception that the transfer 
solution was lx  SSC. Probes were prepared for the Ig H chain 
joining region (J,; 37), and the major breakpoint cluster region 
characteristic of the t(14;18) in FL, pFL1 (7). Additional probes 
were obtained from regions 5' of  the rearranged  V gene as described 
in Results. DNA was labeled with c~-[32p]dCTP by random hex- 
amer priming (38). Hybridization and washing conditions were 
as recommended by the membrane manufacturer. 
Oligonucleotides.  Defined  oligonucleotides  were synthesized  by 
Operon  Technologies (Berkeley, CA)  and  were used without 
purification. The oligonucleotides  used in this study have  been de- 
scribed (5). Additional  oligonucleotides  used are indicated  in Results. 
Oligonucleotide Hybridizations.  Oligonudeotides  were labeled 
with "y-[3aP]ATP with polynucleotide kinase (39) for use as hy- 
bridization probes. Colonies were grown in situ on hybridization 
membranes as described  below. Filters were prehybridized at 42~ 
for 3 h in a solution of 6 x SSPE (lx  =  180 mM sodium chloride; 
10 mM sodium phosphate, pH 7.7; I mM EDTA), 10 x Denhardt's 
solution (lx  = 0.02% Ficol1400 [Sigma Chemical Co., St. Louis, 
MO], 0.02% BSA [fraction V; Sigma Chemical Co.], 0.02% poly- 
vinylpyrrolidone  [Sigma  Chemical Co.]), 1% SDS, 20/~g/ml Esch- 
erichia coli tRNA, 50/zg/ml sonicated, single-stranded, salmon 
sperm DNA (Sigma Chemical Co.). Hybridization with radiola- 
beled oligonucleotides was performed at 42~  in 6x  SSPE and 
1% SDS. After 12-16 h, filters were washed in 6x SSPE, 1% SDS 
three times for 10 min at 42~  This was followed  by a final  3-min 
wash in either 0.1x  or lx  SSPE, 1% SDS at 42~  Filters were 
exposed to x-ray film (X-AR; Kodak, Rochester, NY) at  -70~ 
with intensifying screens (Lightening Plus; DuPont  Co.,  Wil- 
mington,  DE) for 3-16 h. 
Plasmid Isolation.  Plasmid  DNA was prepared on exchange  resin 
(Qiagen, Chatsworth, CA) as recommended  by the manufacturer. 
PCR Amplification and Cloning of lg H Chain V Genes.  Produc- 
tively rearranged Ig H chain V genes were amplified  via the PCR 
using family-specific  5' amplimers and a consensus  J, primer (40) 
as previously described (5, 36). Initial templates were either 1/zg 
of genomic DNA or first-strand cDNA prepared from 0.5-3/~g 
of A + P,  NA (41). The amplified  products were either cloned into 
pLIB:AZ or pLIB:ZA or directly sequenced  as previously  described 
(5, 42, 43). Additional clones of the rearranged MT FL V. gene 
were obtained by PCR amplification  using a 5' amplimer from the 
upstream region sequence, USR1, and J.-S as the 3' amplimer. The 
material was  cloned into  the  SmaI site of pBluescript KS(-) 
(Strategene, La  Jolla, CA), which had been dephosphorylated  with 
calf  intestine  alkaline  phosphatase  (Boebringer Mannheim  Biochem- 
icals [B-MB], Indianapolis, IN). 
Molecular Cloning from Size-selected Libraries.  20/zg of genomic 
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endonuclease in buffer supplied by the manufacturer. The DNA 
was resolved in a 0.8% agarose gel (International Biotechnologies, 
Inc., New Haven, CT) run in lx TAE buffer (40 mM Tris acetate, 
pH 8.0, 1 mM EDTA; 39) flanked by 1-kb ladder DNA markers 
(Gibco-BRL, Gaithersburg, MD). A gel slice containing the frag- 
ment size of  interest _+ 1.5 kb was isolated. The size-selected  DNA 
was purified from the gel using GlassMilk  TM  (Biol01, La Jolla, 
CA) and concentration estimated  by ethidinm bromide fluorescence 
(39). To determine if the proper size fraction had been selected, 
one half of the DNA was resolved  by electrophoresis, transferred 
to Zetabind, and hybridized  with the appropriate probe as described 
above. The pBluescript II KS(-) phagemid DNA (Strategene) was 
digested with the appropriate enzyme and dephosphorylated with 
calf intestine alkaline  phosphatase as recommended  by the manufac- 
turer (B-MB). Approximately  20 ng of size-selected  DNA was com- 
bined with 10 ng of dephosphorylated vector DNA and ligated 
2-16 h at 15~  The reaction was diluted to 100/~1 with TE (10 mM 
Tris, pH 8.0, 1 mM EDTA) and extracted sequentially  with phenol- 
chloroform and chloroform alone. To insure quantitative precipita- 
tion, 20/~g of glycogen (B-MB) was added as a carrier molecule. 
Sodium acetate, pH 5.5, was added  to a final  concentration  of  0.3 M. 
DNA was precipitated by the addition of 2.5 vol of ethanol and 
the precipitate was collected by centrifugation.  The pellet was 
washed three times with 500/~1 70% ethanol and the precipitate 
was recollected  by centrifugation after each wash. The DNA was 
resuspended in 10/~1 of MiUi-Q H20 (MiUipore, Bedford, MA) 
and 1 #1 was used to electrotransform  (44) E. coil  SURE (Strategene). 
Libraries were screened at high density with the appropriate probe 
as previously described (45). Candidate clones were picked and 
rescreened at low density until a single isolate was obtained. 
Sequencing.  Double-stranded plasmid and asymmetric PCR 
DNA were sequenced as previously described (5, 46). Sequences 
were analyzed with the assistance of the University of Wisconsin 
Genetic Computer Group programs (47) installed  at the VAX com- 
puter  facility in  the Department  of Cell  Biology at  Stanford 
University. 
Results 
The lgH V Gene of Case MT Is Intraclonally Diverse as the 
Result of  Soma~ Mutation.  In FL, the productively rearranged 
Ig V genes demonstrate intradonal diversity (reviewed in ref- 
erence 30).  To determine if this was also true in the FL of 
case MT, the rearranged V region gene was amplified by the 
PCR  using  consensus  V.  leader  primers  and  the J.-Sfi 
primer (5, 36).  Both eDNA and genomic DNA were used 
as templates. Products of the expected size were obtained only 
with the V.III leader primer,  suggesting that the produc- 
tively rearranged V. gene was from the V.III family (48). 
The PCP, product was cloned into the pLIB:AZ vector as 
previously described (5). Sequences were determined for dunes 
derived from independent amplifications. In Fig. 1, the se- 
quences have been aligned relative to a consensus FL sequence. 
The  sequences  of five  independently  derived  FL  clones 
(MTFC3,8,11;  MTFJ1,2) were extremely homologous to each 
other but there were randomly distributed somatic mutations, 
as has been previously described in FL. The sequence-labded 
rMTF is derived from a genomic done of the rearranged al- 
lele,  as discussed  below. 
Assembly of a productive H chain Ig gene rearrangement 
involves two joining steps: the  juxtaposition of a D segment 
with one of the J, segments followed by the juxtaposition 
of a  V.  gene with  the D-J join  (49,  50).  The joins  are 
imprecise because of the removal of a variable number of  base 
pairs as well as the nontemplated addition of  a variable number 
of base pairs (51). Therefore, the V-D-J join is a important 
marker of donality in Ig H chains. In all the dunes the N-D-N 
sequence was identical in length; and in three dunes (MTFC3, 
MTFCll, MTFJ1) the sequence of this region was identical. 
In done MTFC8 one difference with the consensus was seen, 
and in clone MTFJ2 three differences were observed.  This 
i  Leader>  Intron>  151 
FL  CONSENSUS  ATGGAGTTTGGGCTGAGCTGGGTTTTCCTTGTTGCTATTTTAAAAGGT  GATT•ATGGGGAA•TAGAGATA•TGAGTGTGATGGA•ATGAGTGAGAGAAA•AGTG•A•GTGTGTGG•A•T•FIvCTGA•cAGGGTGT•TCTGTGTTTGCAGGT 
MTFC3  ......  =====  .........  - ...........................  / 
MTFC~  ..........  == ..................................... 
MTFCII  ..........  = .........  - .........................  /  / 
MTFJI  ..........  = .....................................................................................................................................  - 
MTFJ2  ...................................  r  ....................................  r  ......................................................................... 
rMTF  ....................................................  r  .......................................................................  a-a  ........ 
FRI>  CDRI>  F?2>  3,57 
FL  CONSENSUS  GTCCAGTC,TGAGATGCAACTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGAGTCCCTCAAACTCTCCTGTGCAGCCTCTGGATTCTCT•••CAGT  GGTTCTACTATACAC  TGGGTCCGCCAGGCTTCCGGGAGAGGGCTGGAGTGGGTTGGT 
MTFC3  ..................................................................................................................................................... 
MTFCS  ......................................................  t ..............................  t  .......................................................... 
MTFCII  ............................................................................................................................................... 
MTFJI  ..................................  g ...................................................................................................................... 
MTFJ2  .....  ~ .......................................................................................................................................... 
rMTF  ...........  g----g  ....................................  g  ......  g .....................  g---a-r  ........  e---g-g-  g  .........................  ￿9 ..................  r 
CDR2>  FR3>  460 
FL  CONSENSUS  CGTAGTAGAAGCAAAGCTGACAATTTTATGACATCTTACGCTCCGTCGAqAAAAGGC  AAGTTCATCATTTCCAGAGATGATTCCAGCAATATGTTGTATCTTCAAATGAACAACCTGAAAACCGAGGACACGGCCGTCTATTTT••GTACTCGC 
MTFC3  ................................................................................................................................................ 
MTFC8  ..............  g  ........................................................................  ￿9  ...........................  ￿9  ............................... 
MTFCII  .......................................................................................  e  ......................  r  ................................... 
MTF21  ................................  ￿9 .................................................................................................................. 
MTFJ2  ..................................................................................  r  ........................................................... 
rMTF  -￿9  Z----gm  .....  a---g--&r162149149  g---g  .....  g  g  .......  g  .....  c---e  .............  ￿9  ......  ￿9  ..........  g ........  tr  .............................  g 
N  D  S  J  535 
FL  CONSENSUS  AATTTTACCTCTTTGGACTCTACAGGAAATTCCTTTGGCCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA 
MTFC3  ................................................................... 
MTFC8  ...............................  t ....................................... 
MTFCII  ..................................................................... 
MTFJI  ......................................... 
MTFJ2  --c  ...................  ~t  .................. 
rMTF  ---c  ................................... 
Figure  1.  Nucleotide  sequences of the H chain  V gene  from the FL case  MT. Framework  segments (FR1,2,3), complementarity  determining  regions 
(CDR1,2), diversity  segment (D), and joining segments (1) are indicated  according  to I~bat et al. (67). Sequences are aligned  relative to a consensus 
sequence. Clones MTFC3, 8, and 11 are derived from PCP, of cDNA and therefore have no intron sequences. Clones MTFJ1 and 2 are clones of 
the PCR product obtained using genomic  DNA as template. Clone rMTF is a molecular  clone of the productively  rea~anged V gene isolated  from 
a size-selected HindIlI library. Differences  from the consensus are indicated  by the appropriate base change. 
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of independent recombinational events and is similar to the 
variability of this region in other cases of FL (5). Thus, these 
clones are donally related and therefore must be derived from 
the rearranged IgH allele in the FL tumor cells. The sequence 
differences among the individual FL clones probably are the 
result of somatic mutation. 
Sequential Probing of MT FL DNA with J, and bcl-2  Probes 
Identifies the Productively  Rearranged  IgH Allel~  Rearrange- 
ments of the Ig H chain gene and the kl-2 proto-oncogene 
in case MT were analyzed  by Southern blot hybridization 
(Fig.  2). A probe for J. detected non-GL bands of 4.7 and 
5.5 kb in DNA digested with HindlII. Only a single rear- 
rangement was detected at 17 kb in EcoKI-digested DNA. 
The filters were stripped and rehybridized with a probe for 
the major breakpoint region (mbr) of the kl-2 proto-oncogene. 
In HindIII-digested DNA, a non-GL fragment of 4.7 kb was 
detected that comigrated with one of the bands detected with 
the J, probe, indicating this band was derived from the J. 
alelejuxtaposed to bc/-2 as a consequence of the t(14;18) trans- 
location. Thus, the 5.5-kb HindIII fragment detected with 
the J, probe had to be derived from the productively rear- 
ranged Ig allele. Only GL fragments were detected with the 
mbr probe in EcoRI-digested FL DNA, thus with this anal- 
),sis, it not possible to unequivocally assign the 17-kb EcoRI 
fragment to the productive IgH allele. 
An Upstream  Region Probe  from the Productively  Rearranged 
Ig Allele of Case MT Identifies a Unique V Gene.  Since the 
5.5-kb HindIII fragment identified with the J. probe was 
derived from the productively rearranged IgH allde, a size- 
selected (5-6 kb) library of HindlII-digested MT FL genomic 
DNA was prepared in the phagemid pBluescript SK-  and 
screened with the J, probe. A done with a 5.5-kb HindIII 
insert was isolated and designated rMTF. The Ig V gene was 
mapped within the fragment by a PCR assay using 5' am- 
plimers from both the T3 and T7 promoters of the pBluescript 
SK-  and a 3' amplimer from a consensus J, sequence (40). 
USR  L 
MT ,  *  v  I 
VH 
( 
1  O0 bp 
Probes  I  USR2  ,  I 
USR1  t 
Figure 3.  Restriction endonuclease  map of the 2.1-kb USR of the H 
chain V genes  from GL and FL of case MT.  The USRs of the MTGL 
and rMTF clones were amplified by the PCR using the MTVH5' and 
MTIdr-com primers; the amplified fragments were both 2.1 kb. The GL 
PCP, fragment was generated by PCR using the MTVH5 ~  and V.III-sig 
primers yielding a fragment of 2.6 kb, only the restriction map of the 
USK is shown. The restriction maps were generated using standard tech- 
niques. The small left and right arrows beneath the schematic of the locus 
indicate the position of the PCR primers. (#)  Hindlll; (V) Awl; (A) 
Fokl; (4) RsaI. 
A  2.6-kb  fragment  was  amplified  with  the  T7  and  J. 
primers demonstrating that the 5' end of the V  gene was 
downstream of the T7 promoter and the clone had a region 
of '~2.1 kb upstream of the V  gene. Clone rMTF proved 
to be representative  of the rearranged IgH allele in the MT 
FL since the sequence of the N-D-N region was identical, 
albeit with a single T~C point mutation, to the previously 
sequenced  MT FL V. isolates  (Fig.  1).  Like the other se- 
quences, there were scattered differences relative to the con- 
sensus sequence. This intradonal diversity was investigated 
further, see below. 
A restriction map of the USIL is shown in Fig. 3. A probe, 
USR2, was prepared from the 1-kb HindlII-AvalI fragment. 
This probe detects a single band in GL DNA digested with 
HindlII and EcoRI of 6 and 10 kb, respectively (Fig. 2). The 
Figure  2.  Analysis  of  Ig  gene  rearrangements  and 
t(14;18) translocation in case MT FL by Southern blot 
analysis. DNA was isolated from normal sperm (GL) and 
the MT FL tumor specimen.  DNA was digested with 
either HindlI! (H) or EcoKI resolved by dectrophoresis 
in agarose,  transferred to Zetabind hybridization mem- 
brane, and sequentially hybridized  to: a t(14;18) mbr probe, 
pFL1; a J, probe; and the USP,2 probe (see text and Fig. 
3). The migrations of translocated (-*) and productively 
rearranged (=~>) Ig alleles are indicated. 
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MTGL  AAATGGTCAAGTAGAACAATCAG 
MTUSR3 
rMTF  ....................... 
-500  -401 
MTGL  G  TAATTAGG•TGTCGAAGGCAACA•TGCCAAATGACAGCATTTCCGTG•AAACTGCGTGTACATCCAGCA•TCCACCTGTGAACGATGACATCATACCCT 
> 
rHTF  .................................................................................................... 
-400  -301 
MTGL  TCACAGTGTC•AGGAAAGAGACATCACTCAAACAGACAAGCCAAGGGACTTCAGAAAATATAAGGGAAATACAGTGTGCAAATATGTAAAAATGCATAAG 
rMTF  .................................................................................................... 
-300  -201 
MTGL  ATGATTACTCCTAAATGAATATCAAGACACAATCACATAATATGAAATTAAATTTTCCTGAATGATAGGAATACTA•CAATCACcCCCCAGXACACCCTC 
rMTF  .................................................................................................... 
-200  *****''*  -i01 
MTGL  ATCTACTCTGTGCACAG~CTTCTCGTCAGGCGT~CCAGCCCAGACCTTGCTATGTAGCAGAAGACATGCAAATAAGACCCCCCT~TTGCTGATGAAAAG 
MTUSRI> 
rMTF  .................................................................................................... 
-i00  -i 
MTGL  CAGCCCAGCCCTGACCCTGCAGCTCTGGGAGAGGAGCTCCAGCCTTGGGATTCC•AGCTGTCTCCACTCGGTGATCGGCACTGAATACAGGAGACTCACC 
rMTF  .............................................................................................  C  ...... 
Figure 4.  Nuchotide  sequences 
of the USlks of the H chain V genes 
from dones MTGL and rMTF. Base 
- 1 is the first base 5' of the ATG in 
the leader sequence. The position of 
the Oct2 binding site is indicated 
by the asterisks. The single under- 
line indicates the position of the 
MTUSR1 PCR primer; the double 
underline indicates the position of 
the MTUSR2 PCR primer. 
MT FL DNA demonstrated an additional, non-GL band in 
both HindIII- and EcoKI-digested DNA that comigrated with 
the rearranged  alldes detected with the J, probe of 5.5 and 
17 kb, respectively (Fig. 2). This result demonstrates that the 
17-kb  EcoKI  band  detected  with  the  J.  probe  was  the 
productively rearranged  allele. 
Candidate GL  V  Gene Clones Were Selected by Homology 
to the Region Upstream of the rMTF Clone.  The USK1 probe 
was prepared from the entire 2.1-kb region upstream of the 
rMTF done (Fig. 3). USK1 was used to probe a size-selected 
HindIII  library (5.5-6.5  kb),  and  two independent  clones 
were obtained designated V.III-GLA and B; however, other 
than orientation in the cloning vector, they proved to be iden- 
tical and are therefore referred to as V.III-GL.  Restriction 
mapping and sequencing (data not shown) demonstrated that 
the  USK  of V.III-GL  was  not  colinear  with  the  rMTF 
clone. Thus,  these clones do not represent the GL V  gene 
and were likely identified on the basis of the partial homology 
to conserved regulatory and promoter elements immediately 
5' of the V  gene. 
Since the utility of the USK1 probe proved to be limited 
by homology to other V regions, the USK2 probe (Fig. 3) 
was used to screen the size-sdected library of MT FL genomic 
DNA. Two independent clones were isolated and designated 
MTGL1 and 2, and proved to be identical by restriction map- 
ping and partial sequencing;  they are referred to as MTGL. 
The cloned fragment  was 6 kb in length,  consistent with 
that expected from the Southern blotting data (Fig. 2). The 
restriction  map of the USK of the GL done was identical 
to that of the FL (Fig.  3). Partial sequencing of the region 
immediately upstream  of the V  gene for MTGL is shown 
in Fig. 4. There is near sequence identity in the region  -1 
to  -523 bp between the MTGL and rMTF clones. A single 
difference from the USK of rMTF was observed at base  -  7 
consisting of an A--~C;  this presumably arose from somatic 
mutation of the GL sequence. Based on the virtual identity 
of the USKs of the MTGL clones and the rMTF done, we 
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concluded that MTGL1 and 2 were strong candidates to en- 
code the GL version of the V  gene rearranged  in MT FL. 
The Molecular Clones Homologous to the USR Probes Encode 
V,  III Family GL V Genes.  To understand the nature of the 
evolution of the GL V gene to the FL V gene, the sequence 
of the V gene of MTGL was compared with those obtained 
from the productively rearranged  allele  in the FL. The se- 
quences are shown in Fig. 5, which includes the previously 
presented sequence data (Fig.  1); however, all the sequences 
have been aligned relative to the MTGL sequence. Included 
in the data area the sequences of the V genes from four addi- 
tional,  independently derived MT FL sequences, MTFU2, 
4, 5, and 6 (see below). The homology between the MTGL 
V gene sequence and the FL V gene consensus sequence was 
90.7%.  The MTGL V  gene was functional,  as there were 
proper open reading frames and a heptamer-nonamer  signal 
sequence commencing at base 463. Clone MTGL represented 
a new V. gene with >80% homology to genes of the V.III 
family (48). 
The  USR  of MTC,  L  Is Associated with a Single  V  Gene. 
Since the putative GL V gene was quite divergent from the 
FL consensus, it raised the possibility that despite the virtu- 
ally identical USRs between MTGL and the rMTF clones, 
they represented different V genes. The hypothetical alterna- 
tive V gene would have to share nearly identical USRs. To 
determine  if there were multiple  V  genes that  shared the 
common USR of MTGL  and rMTF,  genomic DNA was 
amplified by PCR using a 5' amplimer, MTVH5', which was 
common to both the rMTF and MTGL clones, and a 3' am- 
plimer based on a consensus V.III hepatmer-nonamer  signal 
sequence. The PCR product was 2.6 kb, as expected from 
the molecular clones, and had the identical restriction maps 
(Fig. 3). The PCR product was cloned and the library was 
sequentially hybridized with oligonucleotides specific for the 
CDR2 of the V genes from MTGL or the FL consensus (boxed 
sequences in Fig. 5). In addition,  the colonies were hybrid- 
ized to an USR oligonucleotide that would identify clones I  Leader>  Intron>  151 
MTGL  ATGGAG~'I'~GCTGAGCT~GTTTTCCTTGTT~CTATTTTAAAAGGT  GATTCATGGGGAACTACAGATA~TGAGTGTGAGTGGAcATGAGTGAGAGAAAcAGTGGA~G~CTGTGGcA~T~CTGA~CAGGGTG~AGGT 
MTFC3  ...............  =:===  ............................  /  / 
MTFC8  =====  .....  ==========  ............................  / 
MTFCII  ====================  ............................  / 
MTFJI  ......  ==============  ................................................................................................................................... 
MTFJ2  =====================  -c ......................................  c  ........................................................................... 
MTFUJ2  ...........  ￿9  .......................  a  ......................................  c  ........................................................................... 
MTFUJ4  ...........  ￿9  ..............................................................  ~  ...................................  r  ....................................... 
MTFUJ5  ..........................................................................................................  t  .......................................... 
MTFUJ6  .................................................................................................................................................... 
rMTF  ............................................................  t ...........................................................................  A-￿9  ......... 
FRI>  CDRI>  FR2>  307 
MTGL  GTCCAGTGTGAGGTGCAGCTGGTGGAGTC~GGGGAGG~I~TCCAG~TGGGGGGTCCCTG~C~C~AGC~GG~ACC~AGT  GGCTCTGCTATGCAC  TGGGTCCGCCAGGCTTCCGGGAAAGGGCTGGAGTGGGTTGGC 
FF/7 C 3  ............  A----A  .....................................  A ......  C  .......................  A--  -T-T  ........  T-  - -A-  - - -A  .........................  G  ..................  T 
MTFC8  ............  A--  - -A .....................................  A-  ---t-C  .......................  A---T-T--t  .....  T-  - -A-  - - -A  .........................  G  ..................  T 
MTFCll  ............  A----A  .....................................  A ......  C .......................  A---T-T  ........  T---A----A  .........................  G  .................  T 
MTFJI  ............  A-  - --A  .................  m  ...................  A ......  C  .......................  A---T-T  ........  T-  --A----A  .........................  G  ..................  T 
MTFJ2  .....  t  ......  A--  --A  .....................................  A ......  C  .......................  A---T-T  ........  T-  - -A----A  .........................  G  ..................  T 
MTFUJ2  ............  A--  --A  .....................................  A  ......  C  .......................  A---T-T  ........  T---A----A  .............  t  ...........  G  ..................  T 
MTFUJ4  ............  A--  - -A  .....................................  A  ......  C  .......................  A---T-T  ........  T---A-  ---A  .........................  G  ..................  T 
MTFUJ5  ............  A-  - - -A .....................................  A  ......  C  .......................  A--  -T-T  ........  T--  -A-~-  - -A .........................  G  ..................  T 
MTFUJ6  I----a  ...........  C  ....................................................................  A  ...............  g-  --~-  ..............................  ￿9 ............... 
rMTY  ........................................................................................................................................................  ~- 
CDR2>  FR3.  460 
MTGL  CGTATTAG  AAG  CAAAG  CTAACAG  TTACG  CG  AC  AG  C AT~TG  CTG  CG  TCGGTGAAAGGC]  AG  G TTC  AC  C ATCTCCAGAGATG  ATTC  AAAG  AACACGGCG  TAT  C TG  C AAATGAAC  AG  C CTG  AAAACCGAGGAC  ACGG  C CG  TG  TATTAC  TG  TACTAG  A 
MTFC3  ....  G  .............  G-  - -A-  -TTAT-  - - -T-T-~C---C  .....  A-A  ......  [ -A  .....  T--  -T  ..............  C-GC-  -T-T-TT  ......  T  ..........  A  ........................  C 7 - - -TT  ......  C-C 
MTFC8  ....  G  .........  g--  -.---.--...----.-.--.---.  .....  A-A  .......  A  .....  T---T  ..............  C-GC-  -T-T-AT  ......  T  ..........  A  ........  ￿9  ...............  C-  - - -TT-  .....  C-C 
MTFCI  i  ....  G  .............  "---'----'----'-'--'---"  .....  A-A  .......  A  .....  T---T  ..............  C  -GC  - -T-T-CT  ......  T  ..........  A-  - -I;  ....................  C=---TT  ......  C7C 
MTFJ1  ....  G  .............  G-  - -.--...----'----.---.  .....  A-A  .......  A  ....  T--  -T  ..............  C-GC-  -T-T-TT  ......  T  ..........  A  ........................  C----TT  ......  C-C 
MTFJ2  ....  G  .............  G-  - -.--...----'-'--.---.  .....  A-A  .......  A  .....  T-  - -T ..............  C-GC-  -T-T-~"J  ......  T  ..........  A ........................  C----TT  ......  C-C 
MTFUJ2  ....  G  .............  G-  - -.--...----'-'--.---.  .....  A-A  .......  A  .....  T--  -T ..............  C-GC-  -T-T-TT  ......  T  ..........  A  ........................  C----TT  ......  C-C 
MTFUJ4  ....  G  .............  G-  - -A-  -~'FAT-  - -iT-T-  -C  - - -C .....  A-A  .......  A .....  T--  -T ..............  C-GC--T-T-TT  ......  T ..........  A  ......................  C----TT  ......  C-C 
MTFUJ5  ....  G  .............  G---A--TTAT  .....  T--C---C  .....  A-A  .......  A  .....  T---T  ..............  C-GC-  -T-T-CT  ................  A  ........................  Q----TT  ......  C- 
~.~v ~  .....  ~  ....................  ~  ................................................................  -~- .................  ~  .............  c.---~  ......  c-~ 
461  502 
MTGL  CACACAGTGAGGGGAGGTCAGTGTGAGCCCGGACACAAACT 
*.o****  ********* 
VHIII-SIg  3'  -  CACTCCCCTCCTG  TG'gG  TG  A - 5  ' 
Figure  5.  Nucteotide sequences of the H chain V genes from clones MTGL and rMTE Framework segments (FR1,2,3)  and complementarity deter- 
mining regions (CDR1,2), are indicated according to I~bat et el. (67).  Sequences are aligned relative to the GL V gene clones MTGL1 and 2, which 
were identical and are shown as a single sequence. Differences from the MTGL sequence are indicated by appropriate base changes. The boxed bases 
in clones  rMTF  and MTFUJ6  denote  shared changes in the minor FL clone (see text).  Clones MTFC3,  8, and 11 were  derived from cDNA,  and 
therefore there is no intron sequence. The asterisks denote the position of the heptamer-nonamer sequence. An equal sign denotes sequencing through 
the PCR amplimer. Dots denote missing base pairs. The sequences of the CDR2-specific  olignnudeotides used to demonstrate the unique relationship 
between the USR and the MTGL V gene are boxed.  The sequences of the CDR2-specific oligonucleotides  used in Table I are underlined. The position 
of the V,III-sig PCR primer is indicated. 
containing the PCK insert. All the colonies hybridizing with 
the  USR  oligonucleotide  also hybridized to  the  MTGL 
CDR2-spedfic probe (107/107).  No colonies  hybridized to 
the FL CDR2-specific probe  (0/107).  Thus,  the USR of 
MTGL is present upstream of a single  V  gene;  the differ- 
ences in the V gene sequences of the MTGL clones and the 
FL clones  must be a consequence  of somatic  mutation. 
The  FL Appears to Be  Comprised of Two Dominant Sub- 
clones.  The sequence of the clone of the rearranged allele, 
rMTF, appeared to be much closer to the GL sequence than 
FiE,  re  6.  Schematic model  for 
the follicular lymphomagenesis. FL 
has its origin in the pro-B cell (13) 
where the t(14;18) arises as an error 
of  D-J.  (15,  16)  or  V.-D  (17) 
recombination. The pro-B cell then 
undergoes H  and L chain Ig gene 
rearrangements.  Potentially,  an 
olignclonal  population  could arise 
with multiple H and L chain rear- 
rangements (indicated by ?) though 
they have yet to be unequivocally 
demonstrated.  A  t(14;18) §  B  cell 
with unmutated V genes enters the 
circulation and homes to the LN in 
a process akin to the secondary im- 
mune response. Within the node, 
a hypothetical t(14;18) + centroblast proliferates introducing  somatic mutations into the V genes.  If transformation occurred at this point (as indicated 
by the dotted line), the V genes of the tumor cells would have shared mutations relative to the GL, but there would be no evidence positive  selection 
on the CDRs as in the current dat~ and the data presented by Bahler and Levy (57a). The FL cell is selected, presumably by binding to Ag presented 
on the follicular dentritic cell (FDC) or possibly infiltrating T  cells; as in the current data, multiple clonotypes  may be selected. The data presented 
here suggest a role for antigen in the process of monoclonal expansion; however, whether continual presence of antigen is required remains an unresolved 
question.  The malignant  clonal expansion of the tumor cell  may result from autocrine or paracrine stimulation,  as indicated by the arrows. 
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MTF V  Gene Segment Library 
Positive 
Oligo  Template  colonies  Percent* 
FRlcon  FL  62  - 
MTFCDR2  FL  44  71 
(major) 
rMTFCDR2  FL  18  29 
(minor) 
MT FL genomic DNA was  amplified by PCR using V.3-1dr as the 5' 
amplimer and J.-Sfi as the 3' amplimer.  The PCR product was cloned 
into  pBluescript  II  SK-  and  screened  as  described  in  Materials  and 
Methods using 5'-labeled oligonucleotide  probes as indicated in the table. 
* Percent of colonies hybridizing with the CDK2-specific probe and the 
consensus  framework 1 primer, FRlcon. 
the other sequences obtained  from the FL.  Homology of 
rMTF with the GL was 96.5%  (16 differences) compared 
with the 91.1% (41 differences) homology of the FL con- 
sensus sequence. Examination of the sequence revealed that 
rMTF shared only 4 of the 41 changes seen between the con- 
sensus FL and the GL sequence. These differences  all clustered 
in the 3' end of the V gene between bases 445 and 460 im- 
mediately before the heptamer-nonamer signal sequence. These 
alterations could have arisen during V-D recombination rather 
than as a result of somatic mutation. These differences,  shared 
by all the V gene sequences, support a common clonal origin 
for the various tumor cell populations;  however, the rMTF 
sequence seemed to have evolved  independently from the dom- 
inant population.  To determine if rMTF was a unique se- 
quence, additional clones were generated from a PCR of MT 
FL DNA between an MTUSR3 amplimer (sequence indi- 
cated in Fig. 4) and the J. primer. Four clones were isolated 
and sequenced, MTFUJ2, 4, 5, and 6, and are shown in Fig. 
Table  2.  Distribution of Replacement and Silent Mutations in the 
Relative to the GL Gene 
5.  Clone 6 was very similar to rMTF.  The MTFUJ6 and 
rMTF clones shared nine mutations with each other in addi- 
tion to the four mutations shared with the major clone as 
noted above. The other doneg 2, 4, and 5, were all very similar 
to the dominant population sharing all the changes from GL 
as the FL consensus sequence. 
To quantitatively determine the proportion of the popula- 
tion represented by this variant done, oligonucleotides were 
prepared corresponding to sequences in CDR2 unique for 
either the minor or dominant clones (underlined sequences 
in Fig. 5). The rearranged V gene from MT FL was amplified 
by PCR with V.-3 L and J. amplimers; the resulting PCR 
product was cloned, screened with the CDR2-specific  oli- 
gonudeotides. Additionally, the FR1 oligonudeotide was used 
as a positive control that should hybridize to the V genes 
from both the major and minor FL sequences. The results 
are shown in Table 1.  Of the 62 that hybridized to one of 
the CDR2 primers, 44 (71%) hybridized to the major clone 
oligonudeotide and the remaining 18 (29%) hybridized to 
the minor clone oligonucleotide.  All 62 clones hybridized 
to the universal primer. Thus, the FL clones were composed 
of two major subdones each representing  a significant por- 
tion of the tumor cell population. 
The V Genes of the Two FL Populations Have Undergone An- 
tigenic Selection.  In a randomly mutated sequence the ex- 
pected ratio of replacement to silent mutations (R/S) is 2.9 
(52). Shlomchik et al. (32) have  argued that if a mutated seg- 
ment of DNA has a R/S ratio significantly lower that this 
value it is likely that there was selection to maintain the pro- 
tein sequence (negative selection), as would be expected for 
Ig framework regions. However, R/S ratios >2.9 imply posi- 
tive selection, as expected for mutations in CDR sequences 
resulting  from antigenic  selection. The FL has undergone 
donal selection as indicated by the nonrandom patterns of 
mutations through the V gene when compared with the GL 
sequence. To determine if this sdection could be on the basis 
of antigen, the pattern of R  and S mutations were quanti- 
tated; the results are presented in Table 2. As would be ex- 
Ig Heavy Chain Variable Gene Segements of the MTF 
Total  Expected  Total  Expected 
Tumor  FR1  FR2  FR3  FR  FR*  CDR1  CDR2  CDR  CDR 
FL  major  Replacement  3  1  11  15  24  2  12  14  7 
Silent  3  1  6  11  8  1  1  2  3 
R/S  1.33  1.00  1.43  1.36  2.00  oo  7.00 
FL  minor  Replacement  0  0  3  3  8  0  4  4  2 
Silent  0  0  5  5  3  1  0  1  1 
R/S  -  -  1.00  0.60  0.00  oo  4.00 
* The expected  number of mutations is given by: RpR-F.Xp  =  N  x  proportion of total sequence in PR  x  proportion R; SF~t-EXP =  N  x  propor- 
tion of total sequence in FR  x  proportion S; RcDg-~xp =  N  x  proportion of total sequence in CDR  x  proportion R; SCDR.eXP =  N  x  propor- 
tion of total sequence in CDR  x  proportion S; where N  is the total number of mutations observed,  the proportion of R  or S as calcuhted from 
the genetic code (52) is 0.74 and 0.26, respectively,  and proportion of sequence as FR is 0.77 (237/309)  and proportion as CDR is 0.23 (72/309). 
1143  Zelenetz  et al. pected for a functional  Ig, the FR regions have R/S ratios 
<2.9, which would be expected for random mutation. How- 
ever, the CDRs of the two FL cell subpopulations had R/S 
ratios >2.9.  Since the CDRs are involved in direct contact 
with antigen (53), the finding of high R/S ratios suggests 
the clonal selection observed in these sequences resulted from 
positive selection on the basis of binding ligand by the slg. 
Furthermore, there are more R mutations in the CDRs than 
would be expected by chance. Given a total of n mutations, 
the expected number of replacement mutations in the CDR 
is found by: n  x  Rf  x  CDRf;  where Rf is the expected 
proportion of replacement mutation (0.74) and CDRf is the 
fraction of the V gene encoding the CDR. In both FL cell 
populations,  the observed R mutations in the CDRs exceed 
the expected number of R  mutations:  FL major,  14:7 (ob- 
served/expected);  and FL minor, 4:2. To determine if the excess 
of R  mutations in the CDRs could have arisen by chance, 
the probabilities were determined  by calculating the binomial 
distribution (33). The likelihood that these mutations arose 
by chance are iv  =  0.003  and iv  =  0.10 for the FL major 
and minor sequences, respectively. Furthermore, the proba- 
bilities that the dearth of R  mutations in the FRs arose by 
chance were iv  =  0.002 and iv  -- 0.01 for the FL major and 
minor sequences, respectively.  Thus, there is evidence  of strong 
selection for maintenance of a functional sIg (negative selec- 
tion on the FRs) and support for selection of an altered an- 
tigen binding domain (positive selection of the CDRs). 
Discussion 
Development of FL almost invariably involves the t(14;18) 
chromosomal translocation in which the bcl-2 proto-oncogene 
becomes disregnlated  as a consequence of its translocation 
to the IgH locus. This translocation  is thought to arise in 
the pre-B cell as an error of D-J or V-D joining (13, 15-17). 
However, the disease is recognized clinically as a tumor of 
a mature B cell having undergone H  and L chain Ig rear- 
rangements (54). Furthermore, the recent identification  of 
the translocation in benign tonsil (23) also suggests that the 
activation of bc/-2 is not sufficient to develop the malignant 
phenotype. The data presented in this paper shed light on 
the process of follicular lymphomagenesis.  The finding of 
nonrandomly  distributed mutations in the FL V gene in com- 
parison with the GL V gene demonstrates  that malignant 
clonal expansion occurred after the initiation of somatic mu- 
tation. This would suggest that the additional signals neces- 
sary for clonal expansion are occurring in the malignant fol- 
licle at a stage of  B cell ontogeny akin to the secondary  immune 
response. Furthermore, the pattern of mutation in the FL 
suggests that the V gene has undergone mutation and selec- 
tion, presumably by an antigen. 
These conclusions rest upon the proper identification of 
the GL V gene. Several lines of evidence suggest  that the 
MTGL clones encode the bona fide GL V gene clone, which 
gave rise to the FL. First, the USR2 probe derived from the 
rMTF clone identified only a single GL band with EcoRI, 
HindIII (Fig. 1), and BamHI (data not shown). Furthermore, 
this probe failed to detect any polymorphism in four individ- 
uals when genomic DNA was digested with BamHI, HindlII, 
or EcoRI (data not shown), suggesting that this is not a highly 
polymorphic locus. The USR2 probe was derived from the 
region -1.2 to -2.1 kb upstream of the V gene, which proved 
to be highly specific compared with a probe consisting  of 
the entire 2.1-kb upstream region because it lacked conserved 
regulatory regions immediately 5' of the V gene. When the 
entire 2.1-kb region was used as a probe (USR1),  V genes 
were cloned (V.III-GLA and B) on the basis of homology 
in the region of -1 to  -300 bp, but were otherwise not 
colinear with the USRs of the FL. Using the USR2 probe, 
two independently derived clones were obtained  that were 
identical to each other. In these clones, the 2.1-kb region be- 
tween the HindlII site and the V gene were colinear with 
that of the FL rMTF clone, differing in only a single base 
pair mutation (Fig. 4). The MTGL clones were functional 
GL genes and, like the productively  rearranged IgH allele 
in the FL,  they were members of the VHIII family by se- 
quence homology (48). Furthermore, a one-to-one correla- 
tion was established  between molecular clones expressing this 
USR sequence and also expressing the MTGL V gene. Thus, 
the data support the conclusion that the MTGL clones rep- 
resent the GL sequence for the V gene rearranged in the MT 
FL, and that the differences present in the tumor-derived V 
gene sequence represent  somatically derived variations. 
An understanding of follicular lymphomagenesis requires 
an explanation that accounts for the development of a ma- 
ture B cell tumor from a pre-B cell in which the t(14;18) 
has occurred (Fig. 6). The bc/-2 gene product is a membrane 
protein that is thought to interfere with programmed cell 
death (55). However, expression of the bcl-2 protein alone 
does not result in a fully transformed phenotype (56). Thus, 
cells in which the protein is dysregulated by the t(14;18) chro- 
mosomal translocation are at a survival advantage, but addi- 
tional stimuli are necessary for malignant clonal expansion. 
The finding of nonrandom changes in the FL as compared 
with the GL support  the conclusion that a cell destined to 
become the tumor clone was selected at a time after the initi- 
ation of somatic mutation. In the course of normal B cell 
development,  somatic mutation is felt to occur principally 
in the GC during the secondary immune response. Thus, 
by analogy to normal B cell development, malignant clonal 
expansion occurs within the GC. 
The finding of two distinct subclones within a single FL 
tumor mass suggests that selection occurred in parallel in at 
least two cell populations.  By analysis of the nature of the 
mutations within a V gene, it is possible to infer that selec- 
tion on the basis antigenic binding has occurred (32, 33, 57). 
The R/S ratios for the CDRs of the two FL subclones dem- 
onstrate there has been positive selection, whereas the FRs 
have been negatively selected, as would be expected if the 
slg were selected  by antigen binding. Similar results have been 
obtained in another case of FL that expressed the V.-4-21 
V gene. In that case, comparison of the GL sequence with 
the V gene sequence from a series of biopsies over a number 
of years demonstrates emergence of several clonotypes. Fur- 
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inant clone supported a role for antigenic selection in the 
clonal expansion of the tumor (Bahler and Levy, 57a).  Re- 
cently, Friedman et al. (58) described the evolution ofV gene 
clonotypes in the pathogenesis of an autoreactive human B 
cell lymphocytic lymphoma. Over time, subpopulations of 
the malignant clone emerged and became the dominant clone. 
Furthermore, comparison of the V gene sequences in the lym- 
phoma to the autologous GL V gene suggested that negative 
selective pressure  resulted  in  maintenance of autoantigen 
binding. These similar findings in a distinct histologic sub- 
type of human lymphoma suggest that antigenic selection 
may be a critical event in the pathogenesis of a variety of 
subtypes of human lymphomas. 
In the present case the nature of the antigen is unknown. 
The data suggest positive selective pressure on the cell sur- 
face Ig receptor. This could be in the form of exogenous an- 
tigen, autoantigen, or a regulatory autologous antiidiotypic 
antibody. In the case reported by Friedman et al.  (58),  the 
tumor-derived IgM was specific for a red cell carbohydrate 
antigen, Pr2 (59).  In that case negative selection was neces- 
sary to main antigenic binding encoded by GL-encoded V 
genes with the potential for autoreactivity. However, in other 
cases of autoreactivity, such as RFs or anti-DNA antibodies, 
positive selection for autoreactive clones has been observed 
(32, 57). Interestingly, tumor-derived idiotypes from a series 
of FL were shown to frequently react with a panel of autoan- 
tibodies (60) and thus may be involved in pathogenesis of FL. 
Furthermore, it is impossible from the current data to de- 
termine if the continual presence of antigen is necessary in 
the genesis of the tumor. It is possible that antigen is con- 
tinually required for the maintenance of the FL clone. That 
the FL is composed of two positively selected, donally related 
subpopulations (Table 1) argues that antigenic selection oc- 
curred as the FL mass expanded. However, the finding by 
others of FL tumors that were slg negative suggests that con- 
tinual presence of antigen is not always necessary (61-63). 
Additional genetic or epigenetic events could result in malig- 
nant clonal expansion independent of antigen. For instance, 
expansion of the malignant clone beyond a critical mass could 
allow the tumor to maintain its expansion via an autocrine 
mechanism. Furthermore, it is known that additional cyto- 
genetic abnormalities can coexist with the t(14;18)  translo- 
cation without resulting in histologic transformation. These 
additional changes can portend more aggressive clinical be- 
havior (64), which is reflected on the cellular level as a selec- 
tive grovcth advantage. Furthermore, as the FL cell mass ex- 
pands additional genetic alterations can occur. At some point 
a single cell within the FL population undergoes further trans- 
formation, giving rise to a histologically distinct transformed 
diffuse lymphoma (5). 
In conclusion, we propose that FL undergoes malignant 
donal expansion under sdection by antigen in a process akin 
to B cdl maturation during the secondary immune response. 
Our current modal for follicular lymphomagenesis is presented 
in Fig. 6. As an error of D-J or V-D joining, the bcl-2 proto- 
oncogene is activated as a consequence of the t(14;18) trans- 
location in a pre-B cell. Since there is proliferation in the pre-B 
cell compartment during V gene rearrangement (65), poten- 
tially multiple productive H and L chain rearrangements could 
occur. However, FL invariably originates from a cell bearing 
a singie VH and VL rearrangement (54; our unpublished ob- 
servations). Cdls with other Ig V gene rearrangements de- 
rived from the same pre-B cell in which the t(14;18) translo- 
cation occurred probably do not undergo malignant donal 
expansion because the subsequent  steps necessary in lym- 
phomagenesis have not occurred. A virgin B cdl with un- 
mutated V  genes and the t(14;18)  translocation enters the 
circulation and migrates to the LN.  Drawing a paralld to 
normal B cell ontogeny, the cell devdops into a t(14;18)-bearing 
centroblast capable of somatic mutation and proliferation. 
At this point the rearranged V genes are randomly mutated. 
Some cells in this population are mutated in such a way that 
they can bind to antigen and are therefore selected. The finding 
of two selected populations in the current data suggest that 
more than one combination of mutations can result in selec- 
tion. After sdection, the cell then undergoes clonal expan- 
sion, either the result of exogenous (paracrine) or endoge- 
nous (autocrine) signals, and possibly as the result of additional 
genetic abnormalities. Previous work has demonstrated that 
in vitro proliferation of FL is dependent on T  call factors 
and contact (66),  possibly reflecting an in vivo dependence 
on a similar environment. The progeny of this done retain 
the ability to home to the LN and bone marrow, possibly 
as the result of expression of VLA-4 or other adhesion mole- 
cules (25), and thus are disseminated to other nodes. Within 
the LN, further clonal expansion results in the clinical pre- 
sentation typical of FL. The alternative modal, which would 
also account for shared mutations, hypothesizes that acquisi- 
tion of additional genetic changes after initiation of somatic 
mutation, but before antigenic selection, gives that done a 
growth advantage. In this alternative modal, the shared mu- 
tations would be randomly distributed with respect to, and 
would not provide evidence for, positive selection of the CDP,  s 
and negative selection of the FRs. The modd, as supported 
by the data, does not preclude another critical genetic event 
occurring subsequent to the t(14;18) translocation; however, 
it does support a role for antigenic selection of the malignant 
done before expansion into a clinically evident mass. 
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